Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

404 studies match

clinicaltrialsPublishedShowing 251–300 of 404 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03326674	Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC(CONTESSA)	terminated	Phase 3	685	Odonate Therapeutics, Inc.INDUSTRY	19	Jul 30, 2021	clinicaltrials
NCT03033511	A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)(MERU)	terminated	Phase 3	748	AbbVieINDUSTRY